Alcon AG reported $6.62B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
AstraZeneca USD 29.61B 890M Mar/2026
Bayer EUR 35.3B 2.39B Mar/2026
Essilor EUR 12.01B 981M Dec/2025
Fresenius EUR 11.03B 1.03B Dec/2025
Fresenius Medical Care EUR 8.11B 209.55M Mar/2026
GlaxoSmithKline GBP 17.76B 251M Mar/2026
GRIFOLS EUR 5.25B 180M Mar/2026
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 14.16B 932M Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Philips EUR 9.78B 148M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.16B 789M Mar/2026
Smith & Nephew USD 4.63B 169M Dec/2025
Sonova Holding CHF 1.91B 466.3M Jun/2025
UCB EUR 6.05B 733M Dec/2025